ADC Therapeutics SA (ADCT)
2.82
-0.48
(-14.55%)
USD |
NYSE |
Jun 17, 16:00
2.99
+0.17
(+6.03%)
Pre-Market: 08:13
ADC Therapeutics Revenue (Annual): 69.56M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 69.56M |
December 31, 2022 | 209.91M |
December 31, 2021 | 33.92M |
December 31, 2020 |
Date | Value |
---|---|
December 31, 2019 | 2.34M |
December 31, 2018 | 1.14M |
December 31, 2017 | 1.803M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
2.34M
Minimum
2019
209.91M
Maximum
2022
78.93M
Average
51.74M
Median
Revenue (Annual) Benchmarks
Roche Holding AG | 67.31B |
Novartis AG | 46.66B |
AC Immune SA | 16.48M |
CRISPR Therapeutics AG | 370.00M |
Addex Therapeutics Ltd | 1.796M |